Skip to content

Clinical study on the effect of nutritional intervention on chemotherapy tolerance and quality of life in postoperative chemotherapy patients with colorectal cancer

Clinical study on the effect of nutritional intervention on chemotherapy tolerance and quality of life in postoperative chemotherapy patients with colorectal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077288
Enrollment
Unknown
Registered
2023-11-03
Start date
2022-12-31
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Intervention group:Provide evidence-based nutritional interventions based on routine nutritional guidance programs.
Control group:Routine nutrition guidance plan

Sponsors

Zunyi Medical University Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-70 years old; (2) Patients with postoperative pathological stage II/III colorectal cancer who plan to undergo CapeOX chemotherapy regimen; (3) NRS2002 score = 3 points; (4) Conscious and without mental, intellectual, or language communication barriers; (5) Patients and their families are aware of this study and have signed a written informed consent form, capable of completing the questionnaire survey.

Exclusion criteria

Exclusion criteria: (1) Merge mental disorders that cannot withstand research and intervention measures, including those with a history of mental illness or family mental illness, or those who are taking medication to treat mental illnesses; (2) Those who have received neoadjuvant chemotherapy before surgery; (3) Those who merge with other malignant tumors; (4) Merge primary disease individuals who have an impact on the study outcome before the start of the study.

Design outcomes

Primary

MeasureTime frame
Chemotherapy tolerance;

Secondary

MeasureTime frame
Quality of life;Nutritional status;Adverse reactions to chemotherapy;

Countries

China

Contacts

Public ContactYin Chunmei; Zheng Xilan

Zunyi Medical University Affiliated Hospital

261074334@qq.com+86 152 8311 2900

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026